Infliximab and occult hepatitis B infection: to treat or not to treat?

Int J Rheum Dis. 2013 Aug;16(4):377-8. doi: 10.1111/1756-185X.12184.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / epidemiology*
  • Female
  • Hepatitis B / epidemiology*
  • Hepatitis B virus*
  • Humans
  • Infliximab
  • Male

Substances

  • Antibodies, Monoclonal
  • Infliximab